Patents by Inventor Peter P. K. Ho

Peter P. K. Ho has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Treatment of inflammatory bowel disease
    Patent number: 5294630
    Abstract: Inflammatory bowel disease is treated, and patients are protected from a relapse into active disease, by the administration of a compound chosen from a series of 3-phenyl-5-carboxypyrazoles and isothiazoles.
    Type: Grant
    Filed: July 7, 1992
    Date of Patent: March 15, 1994
    Assignees: Eli Lilly and Company, London Hospital Medical College
    Inventors: David Blake, Peter P. K. Ho, Jill A. Panetta, David Rampton, Nicola Simmonds
  • Method of inhibiting superoxide release
    Patent number: 4863923
    Abstract: A method of inhibiting superoxide release and reducing tissue damage following an inflammatory or ischemic event employing benzothiophenes, benzofurans, and naphthalenes is disclosed.
    Type: Grant
    Filed: July 1, 1988
    Date of Patent: September 5, 1989
    Assignee: Eli Lilly and Company
    Inventors: Peter P. K. Ho, Jill A. Panetta
  • Antiasthmatic method
    Patent number: 4617311
    Abstract: This invention provides a method of treating asthma in mammals which comprises administering an effective amount of Pinacidil.
    Type: Grant
    Filed: May 17, 1985
    Date of Patent: October 14, 1986
    Assignee: Eli Lilly and Company
    Inventor: Peter P. K. Ho
  • Benzothiophene derivatives
    Patent number: 4552891
    Abstract: This invention provides for pharmaceutical formulations of certain benzothiophene derivatives and a method of using the derivatives or formulations for the treatment of asthma.
    Type: Grant
    Filed: September 13, 1983
    Date of Patent: November 12, 1985
    Assignee: Eli Lilly and Company
    Inventors: Peter P. K. Ho, Quentin F. Soper
  • 2(4-Fluorophenyl)-4,5,-bis(4-methoxyphenyl)thiazole and method of use
    Patent number: 4322428
    Abstract: Novel triaryl thiazole compounds are useful as analgesic agents. In particular, 2-(4-halophenyl)-4,5-bis(4-methoxyphenyl)thiazoles are used. These compounds are prepared by condensation of a substituted thiobenzamide with a substituted desyl chloride.
    Type: Grant
    Filed: April 2, 1980
    Date of Patent: March 30, 1982
    Assignee: Eli Lilly and Company
    Inventors: Ken Matsumoto, Peter P. K. Ho
  • 5,6-Diaryl-1,2,4-triazines as topically-active anti-inflammatory agents
    Patent number: 4021553
    Abstract: A method of treating inflammation which utilizes topically-active 5,6-diaryl-1,2,4-triazines having the formula, ##STR1## wherein R is hydrogen or --(X).sub.n R.sub.1, in which X is either O or S, n is an integer which is either 0 or 1, and R.sub.1 is C.sub.1 -C.sub.8 alkyl, C.sub.7 -C.sub.8 aralkyl, C.sub.3 -C.sub.8 cycloalkyl, or C.sub.4 -C.sub.8 (cycloalkyl)alkyl; and R.sub.2 and R.sub.3 independently are C.sub.1 -C.sub.3 alkoxy or di(C.sub.1 -C.sub.3 alkyl)amino; and the pharmaceutically-acceptable acid addition salts of basic members thereof.
    Type: Grant
    Filed: March 10, 1976
    Date of Patent: May 3, 1977
    Assignee: Eli Lilly and Company
    Inventors: William B. Lacefield, Peter P. K. Ho
  • 5,6-Diaryl-1,2,4-triazines as topically-active anti-inflammatory agents
    Patent number: 4018923
    Abstract: A method of treating inflammation which utilizes topically-active 5,6-diaryl-1,2,4-triazines having the formula, ##STR1## wherein R is hydrogen or --(X).sub.n R.sub.1, in which X is either O or S, n is an integer which is either 0 or 1, and R.sub.1 is C.sub.1 -C.sub.8 alkyl, C.sub.7 -C.sub.8 aralkyl, C.sub.3 -C.sub.8 cycloalkyl, or C.sub.4 -C.sub.8 (cycloalkyl)alkyl; and R.sub.2 and R.sub.3 independently are halo, C.sub.1 -C.sub.3 alkyl, C.sub.1 -C.sub.3 alkoxy, or di(C.sub.1 -C.sub.3 alkyl)amino, with the proviso that at least one of R.sub.2 and R.sub.3 is halo or C.sub.1 -C.sub.3 alkyl; and the pharmaceutically-acceptable acid addition salts of basic members thereof.
    Type: Grant
    Filed: March 10, 1976
    Date of Patent: April 19, 1977
    Assignee: Eli Lilly and Company
    Inventors: William B. Lacefield, Peter P. K. Ho